SCHEMBL477320

SCHEMBL477320

COc1ccc(C(O)c2ccccc2)cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.58
L3MBTL1 Q9Y468 2/20 0.57
TDP1 Q9NUW8 1/20 0.57
LMNA P02545 1/20 0.54
GAA P10253 1/20 0.54
HTT P42858 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
PPARG P37231 1/20 0.53
PPARD Q03181 1/20 0.53
PPARA Q07869 1/20 0.53
ACHE P22303 2/20 0.53
MAPT P10636 1/20 0.53
CRHBP P24387 1/20 0.53
CRHR2 Q13324 1/20 0.53
KMT2A Q03164 2/20 0.52
ADRB2 P07550 1/20 0.48
CYP1A2 P05177 2/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22420293 0.91 CNR2 (0.54) CNR2L3MBTL1TDP1LMNAGAA
SCHEMBL6656697 0.90 PPARG (0.61) L3MBTL1TDP1LMNAGAAHTT
SCHEMBL10702236 0.87 PDE4A (0.53) CNR2L3MBTL1TDP1LMNAGAA
SCHEMBL28172949 0.85 PPARG (0.62) L3MBTL1TDP1LMNAGAAHTT
SCHEMBL25688701 0.85 PPARG (0.57) L3MBTL1LMNAGAAHTTSMN1; SMN2
SCHEMBL13127055 0.84 CNR2 (0.57) CNR2L3MBTL1TDP1LMNASMN1; SMN2
SCHEMBL22420326 0.84 LMNA (0.53) L3MBTL1TDP1LMNAGAAHTT
SCHEMBL22867983 0.84 LMNA (0.51) CNR2L3MBTL1TDP1LMNAGAA
SCHEMBL2782524 0.84 CNR2 (0.54) CNR2L3MBTL1TDP1LMNAGAA
SCHEMBL7633199 0.84 TOP2A (0.54) CNR2L3MBTL1TDP1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11840508-B2 Catalyst system for olefin polymerization and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2023-12-12 US disclosed
US-20220251016-A1 CATALYST SYSTEM FOR OLEFIN POLYMERIZATION AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2022-08-11 US disclosed
EP-4006061-A1 CATALYST SYSTEM FOR OLEFIN POLYMERIZATION AND USE THEREOF China Petroleum & Chemical Corporation (CN) 2022-06-01 EP disclosed
WO-2021236563-A1 BIOMASS-DERIVED PHOTOINITIATORS BOWLING GREEN STATE UNIVERSITY (US) 2021-11-25 WO disclosed
US-10772858-B2 Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2020-09-15 US disclosed
US-8563786-B2 Method for producing optically active alcohol MITSUI CHEMICALS, INC. (JP) 2013-10-22 US disclosed
US-20120088938-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2012-04-12 US disclosed
EP-2412694-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL Mitsui Chemicals, Inc. (JP) 2012-02-01 EP disclosed
CN-101085724-A Method for preparing aldehydes and ketones by oxidizing alcohol compounds UNIV NORTHWEST NORMAL (CN) 2007-12-12 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11840508-B2 Catalyst system for olefin polymerization and use thereof SQSTM1, SAMM50, HPD CNR2 1966/4885L3MBTL1 4692/4885TDP1 4274/4885
US-20120088938-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL ADH1A, ADH1C, FHIT CNR2 1382/4885L3MBTL1 4093/4885TDP1 4360/4885
US-20220251016-A1 CATALYST SYSTEM FOR OLEFIN POLYMERIZATION AND USE THEREOF SQSTM1, SAMM50, HPD CNR2 1966/4885L3MBTL1 4692/4885TDP1 4274/4885
US-10772858-B2 Benzhydrol derivatives for the management of conditions related to hypoxia inducible factors HIF1A, HIF1AN, EGLN2 CNR2 474/4885L3MBTL1 1519/4885TDP1 3421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.